These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6184418)

  • 61. Site recognition by protein-primed T cells shows a non-specific peptide size requirement beyond the essential residues of the site. Demonstration by defining an immunodominant T site in myoglobin.
    Bixler GS; Bean M; Atassi MZ
    Biochem J; 1986 Nov; 240(1):139-46. PubMed ID: 2435278
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The antibody response to myoglobin--I. Systematic synthesis of myoglobin peptides reveals location and substructure of species-dependent continuous antigenic determinants.
    Rodda SJ; Geysen HM; Mason TJ; Schoofs PG
    Mol Immunol; 1986 Jun; 23(6):603-10. PubMed ID: 2427938
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preparation of T-lymphocyte lines and clones with specificities to preselected protein sites by in vitro passage with free synthetic peptides: demonstration with myoglobin sites.
    Yoshioka M; Bixler GS; Atassi MZ
    Mol Immunol; 1983 Oct; 20(10):1133-7. PubMed ID: 6609306
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Limited T cell receptor beta-chain usage in the sperm whale myoglobin 110-121/E alpha dA beta d response by H-2d congenic mouse strains.
    Sellins KS; Danska JS; Paragas V; Fathman CG
    J Immunol; 1992 Oct; 149(7):2323-7. PubMed ID: 1382096
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Genetic control of the immune response to myoglobins. VI. Distinct Ir genes for different myoglobins: complementing genes in I-A and H-2D for equine myoglobin.
    Berzofsky JA; Buckenmeyer GK; Hicks G
    J Immunol; 1982 Feb; 128(2):737-41. PubMed ID: 6798122
    [No Abstract]   [Full Text] [Related]  

  • 66. Precise determination of protein antigenic structures has unravelled the molecular immune recognition of proteins and provided a prototype for synthetic mimicking of other protein binding sites.
    Atassi MZ
    Mol Cell Biochem; 1980 Aug; 32(1):21-43. PubMed ID: 6160381
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Properties of monoclonal antibodies specific for determinants of a protein antigen, myoglobin.
    Berzofsky JA; Hicks G; Fedorko J; Minna J
    J Biol Chem; 1980 Dec; 255(23):11188-91. PubMed ID: 6160146
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunochemistry of sperm-whale myoglobin--XXIII. Investigation of the independence of the five antigenic reactive regions by immunoabsorbent studies.
    Atassi MZ; Koketsu J
    Immunochemistry; 1975 Sep; 12(9):741-4. PubMed ID: 53191
    [No Abstract]   [Full Text] [Related]  

  • 69. Genetic control of the immune response to myoglobin. VI. Inter-site influences in T-lymphocyte proliferative response from analysis of cross-reactions of ten myoglobins in terms of substitutions in the antigenic sites and in environmental residues of the sites.
    Atassi MZ; Yokota S; Twining SS; Lehmann H; David CS
    Mol Immunol; 1981 Oct; 18(10):945-8. PubMed ID: 6977699
    [No Abstract]   [Full Text] [Related]  

  • 70. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.
    Milich DR; Leroux-Roels GG; Louie RE; Chisari FV
    J Exp Med; 1984 Jan; 159(1):41-56. PubMed ID: 6198427
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Ir gene control of antigenic sites (author's transl)].
    Okuda K
    Tanpakushitsu Kakusan Koso; 1980 Feb; 25(2):113-22. PubMed ID: 6162172
    [No Abstract]   [Full Text] [Related]  

  • 72. Does the amount of thyroglobulin antigen influence the severity and genetic control of murine autoimmune thyroiditis?
    Vladutiu AO
    Immunol Lett; 1983 Mar; 6(3):155-9. PubMed ID: 6407982
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic control of the immune response to myoglobin. 3. Autoimmune T-lymphocyte proliferative response to mouse myoglobin.
    Yokota S; David CS; Atassi MZ
    Mol Immunol; 1980 Aug; 17(8):1079-82. PubMed ID: 6777665
    [No Abstract]   [Full Text] [Related]  

  • 74. Prediction and conformation by synthesis of two antigenic sites in human haemoglobin by extrapolation from the known antigenic structure of sperm-whale myoglobin.
    Kazim AL; Atassi MZ
    Biochem J; 1977 Oct; 167(1):275-8. PubMed ID: 73374
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T cells.
    Van Noort JM; Boon J; Van der Drift AC; Wagenaar JP; Boots AM; Boog CJ
    Eur J Immunol; 1991 Sep; 21(9):1989-96. PubMed ID: 1716206
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Genetic control of the immune response. Frequency and characteristics of antigen-binding cells in high and low responder mice.
    Hämmerling GJ; Masuda T; McDevitt HO
    J Exp Med; 1973 May; 137(5):1180-200. PubMed ID: 4121927
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic control of the immune response to myoglobins. IV. Inhibition of determinant-specific Ir gene-controlled antigen presentation and induction of suppression by pretreatment of presenting cells with anti-Ia antibodies.
    Berzofsky JA; Richman LK
    J Immunol; 1981 May; 126(5):1898-904. PubMed ID: 6163822
    [No Abstract]   [Full Text] [Related]  

  • 78. Immune responses to complex protein antigens I. MHC control of immune responses to bovine albumin.
    Riley RL; Wilson LD; Germain RN; Benjamin DC
    J Immunol; 1982 Oct; 129(4):1553-8. PubMed ID: 6180016
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Original antigenic sin: experiments with a defined antigen.
    East IJ; Todd PE; Leach SJ
    Mol Immunol; 1980 Dec; 17(12):1539-44. PubMed ID: 6170878
    [No Abstract]   [Full Text] [Related]  

  • 80. The role of the thymus in a genetically controlled defect of the immune response at the carrier level.
    Mozes E; Sela M
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1574-7. PubMed ID: 4133852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.